- Home
- COYA vs VXRT Comparison
COYA vs VXRT Comparison
Compare COYA & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- VXRT
- Stock Information
- Founded
- COYA 2020
- VXRT N/A
- Country
- COYA United States
- VXRT United States
- Employees
- COYA N/A
- VXRT N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- COYA Health Care
- VXRT Health Care
- Exchange
- COYA Nasdaq
- VXRT Nasdaq
- Market Cap
- COYA 108.4M
- VXRT 119.0M
- IPO Year
- COYA 2022
- VXRT N/A
- Fundamental
- Price
- COYA $6.31
- VXRT $0.37
- Analyst Decision
- COYA Strong Buy
- VXRT Strong Buy
- Analyst Count
- COYA 4
- VXRT 2
- Target Price
- COYA $17.00
- VXRT $3.00
- AVG Volume (30 Days)
- COYA 85.7K
- VXRT 1.8M
- Earning Date
- COYA 03-18-2025
- VXRT 03-20-2025
- Dividend Yield
- COYA N/A
- VXRT N/A
- EPS Growth
- COYA N/A
- VXRT N/A
- EPS
- COYA N/A
- VXRT N/A
- Revenue
- COYA $3,554,061.00
- VXRT $28,700,000.00
- Revenue This Year
- COYA $61.45
- VXRT N/A
- Revenue Next Year
- COYA N/A
- VXRT $48.02
- P/E Ratio
- COYA N/A
- VXRT N/A
- Revenue Growth
- COYA N/A
- VXRT 288.94
- 52 Week Low
- COYA $4.75
- VXRT $0.37
- 52 Week High
- COYA $10.24
- VXRT $1.30
- Technical
- Relative Strength Index (RSI)
- COYA 45.71
- VXRT 27.02
- Support Level
- COYA $6.36
- VXRT $0.49
- Resistance Level
- COYA $7.06
- VXRT $0.60
- Average True Range (ATR)
- COYA 0.45
- VXRT 0.04
- MACD
- COYA -0.03
- VXRT -0.01
- Stochastic Oscillator
- COYA 20.21
- VXRT 1.09
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.